Tech Support

TECHNICAL SUPPORT
+1.800.674.3430

This line is for technical support.
For General Enquiries please click General Contact

x

Blog

Welcome to CrownBio’s Blog where we share our thoughts
on the latest trends and hot stories in Oncology and CVMD

blog.png
June 13, 2019 Comparing Traditional Rodent Models for Metabolic Research Explore the main features, advantages, and limitations of common rodent models used in preclinical metabolic disease research. LEARN MORE
May 8, 2019 NASH Induction with CCl4 Learn more about NASH induction through CCl4 administration, and the advantages of inducing NASH in a dysmetabolic ... LEARN MORE
April 16, 2019 5 Criteria for Choosing a Contract Research Organization Contract research organizations (CROs) vary in capability, quality, experience, cost, and ease of collaboration. Weigh ... LEARN MORE
February 13, 2019 Safety and Efficacy Testing of Anti-Obesity Drugs with NHPs Learn how NHP models provide a more human disease-relevant platform for enhanced preclinical safety and efficacy ... LEARN MORE
January 17, 2019 New Biomarkers to Detect Atrial Fibrillation Review the new data identifying brain natriuretic peptide and FGF-23 as biomarkers for detecting atrial fibrillation in ... LEARN MORE
January 2, 2019 Stress Keeping You Up at Night? Blame Your HPA Axis New research into our master “circadian clock” explains why your body responds differently to stress at different times ... LEARN MORE
December 27, 2018 Biomarkers for Dementia and Alzheimer’s Disease Over 47 million people worldwide are living with dementia, the great majority of them due to Alzheimer’s disease (AD). It’s an extremely difficult situation to see someone you love suffering from dementia. LEARN MORE
December 13, 2018 Obesity, Cancer Development, and Immunotherapy Response How does obesity impact cancer development and immunotherapy response? Find out in our review of cutting-edge combined ... LEARN MORE
December 6, 2018 Exercise, Liver Cancer, and NAFLD Mortality Our current understanding of the mechanisms linking obesity and liver cancer is poor. Preclinical research links ... LEARN MORE
October 5, 2018 Artificial Intelligence for Life Science Diagnostics There are multiple forms of artificial intelligence (AI), including deep learning, neural networks, Bayesian networks, ... LEARN MORE
September 11, 2018 Using Plasma Ceramides to Predict Coronary Artery Disease Cardiovascular disease (CVD) is the number one cause of death globally, making improved prognostic disease indicators an urgent priority. Are ceramides a potential biomarker for our risk of CVD and coronary artery disease? LEARN MORE
August 2, 2018 Are Noninvasive Tests Enough for NAFLD/NASH Diagnosis? There is significant interest in validating strategies for the noninvasive evaluation of fibrosis in NAFLD/NASH. This ... LEARN MORE
July 24, 2018 Improving Cardiac Function with FTY720 – ADA 2018 Our ADA presentations this year included a collaborative poster with Pegasus Bio. The studies used our unique panel of ... LEARN MORE
July 19, 2018 Connecting Inflammation, Diabetes, and Obesity We presented data on our next generation type 2 diabetes (T2D) and obesity rodent models at the ADA Scientific Sessions ... LEARN MORE
July 17, 2018 Cardiomyopathy Treatment in Rodent Models – ADA 2018 At ADA 2018, we shared the latest data on our next generation type 2 diabetes (T2D) and obesity rodent models. This ... LEARN MORE